Drug ads can subtly sway AI medical treatment recommendations
As people increasingly turn to artificial intelligence (AI) for health information, a new study by researchers at the Icahn School of Medicine at Mount Sinai raises questions about what happens when commercial advertising appears alongside a clinical question.
Read original article on The Medical News →Related news
-
Little-known protein offers a potential target for treating Chagas disease
United Kingdom
-
We cannot predict the development of social anxiety from brain scans, study says
United Kingdom
-
Low-cost parenting app reduces sexual violence against adolescent girls by more than half, study finds
United Kingdom
-
What families should know about postpartum psychosis
United Kingdom
-
Urgent care emerges as a promising setting for imaging low back pain
United Kingdom
-
More than a warning sign: Common cardiovascular biomarker may contribute to disease
United Kingdom
-
Researchers identify previously unknown cause of fatal newborn brain disorder
United Kingdom
-
Replacement PFAS chemical still harms developing zebrafish embryos
United Kingdom